Author:
Fain Kevin,Daubresse Matthew,Alexander G. Caleb
Publisher
American Medical Association (AMA)
Cited by
52 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A descriptive analysis of postmarketing requirement studies and clinical trials;Pharmacoepidemiology and Drug Safety;2023-11-23
2. Special FDA designations for drug development: orphan, fast track, accelerated approval, priority review, and breakthrough therapy;The European Journal of Health Economics;2023-11-14
3. Cancer Drug Prices in the United States: Efficacy, Innovation, Clinical Trial Evidence, and Epidemiology;Value in Health;2023-11
4. Cancer Drug Prices in the US: Efficacy, Innovation, Clinical Trial Evidence, and Epidemiology;SSRN Electronic Journal;2023
5. Fulfillment of Postmarket Commitments and Requirements for New Drugs Approved by the FDA, 2013-2016;JAMA Internal Medicine;2022-11-01